Loading...
ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1
BACKGROUND: A-disintegrin and metalloproteinases (ADAMs) are members of a family of multidomain transmembrane and secreted proteins. Specific ADAMs are upregulated in human cancers and correlated with tumor progression and poor outcome, but rarely studied in human hilar cholangiocarcinoma (HC). This...
Saved in:
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5960197/ https://ncbi.nlm.nih.gov/pubmed/29776401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4294-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|